FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39254811000001109: Tagrisso 40mg tablets (Originalis B.V.) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1720191000001116 Tagrisso 40mg tablets (Originalis B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1720201000001119 Tagrisso 40mg tablets (Originalis B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tagrisso 40mg tablets (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Is a Osimertinib 40mg tablets true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Is a Tagrisso true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Has specific active ingredient Osimertinib mesilate true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Osimertinib true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tagrisso 40mg tablets (Originalis B.V.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tagrisso 40mg tablets (Originalis B.V.) 30 tablet Has AMP True Tagrisso 40mg tablets (Originalis B.V.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start